Jupiter Research Capital (Asia) Ltd’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Jupiter Research Capital (Asia) Ltd's AMPH Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd reduced its Amphastar Pharmaceuticals (AMPH) stake by 26% in Q3 2026, selling an estimated $90.1K and leaving 11,732 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #489.
Jupiter Research Capital (Asia) Ltd first reported a position in AMPH in Q2 2026 and has held it in 2 quarters since. The position peaked at $321K in Q2 2026. 219 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 11,732 shares of Amphastar Pharmaceuticals worth $303K as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd sold 4,167 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $90.1K.
- Amphastar Pharmaceuticals made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #489 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Amphastar Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Jupiter Research Capital (Asia) Ltd's Amphastar Pharmaceuticals position peaked at $321K in Q2 2026.
- 219 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.